Penumbra (PEN) Return on Capital Employed (2015 - 2026)
Penumbra (PEN) reported Return on Capital Employed of 11.34% for Q1 2026, up 866.0% year-over-year from 1.17% in Q1 2025, and down 4.02% quarter-over-quarter from 11.81% in Q4 2025.
Penumbra (PEN) Return on Capital Employed (2015 - 2026) Analysis & Trends
Penumbra (PEN) has 12 years of Return on Capital Employed data on file, last reported at 11.34% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 11.34%, up 866.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 11.34% (up 866.0% YoY), and the FY2025 annual result was 12.64%, up 1197.0% from the prior year.
- Return on Capital Employed eased to 11.34% in Q1 2026 per PEN's latest filing, from 11.81% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 11.81% in Q4 2025 and troughed at 3.27% in Q3 2022.
- A 5-year average of 3.39% and a median of 2.67% in 2025 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed sank 471 bps in 2024, then jumped 1230 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 0.51% in 2022, then soared by 967 bps to 5.4% in 2023, then tumbled by 87 bps to 0.69% in 2024, then soared by 1616 bps to 11.81% in 2025, then slipped by 4 bps to 11.34% in 2026.
- Business Quant data shows PEN's Return on Capital Employed at 11.34% in Q1 2026, 11.81% in Q4 2025, and 11.22% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 11.13% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 9.30% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 24.24% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 11.57% |
| 10 | Penumbra | 12.51 Bn | 11.90 Bn | 253.41 Mn | 11.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.34% |
| Dec 31, 2025 | 11.81% |
| Sep 30, 2025 | 11.22% |
| Jun 30, 2025 | 10.79% |
| Mar 31, 2025 | 2.67% |
| Dec 31, 2024 | 0.69% |
| Sep 30, 2024 | 0.11% |
| Jun 30, 2024 | -1.51% |
| Mar 31, 2024 | 5.49% |
| Dec 31, 2023 | 5.40% |
| Sep 30, 2023 | 3.32% |
| Jun 30, 2023 | 2.85% |
| Mar 31, 2023 | 1.47% |
| Dec 31, 2022 | 0.51% |
| Sep 30, 2022 | -3.27% |
| Jun 30, 2022 | -3.03% |
| Mar 31, 2022 | -2.19% |
| Dec 31, 2021 | -0.76% |
| Mar 31, 2021 | -3.62% |
| Dec 31, 2020 | -5.48% |